A new tool has received clearance from the U.S. Food and Drug Administration to be used in patients' homes, where it is meant to aid disease management efforts for those with respiratory conditions. The device, called the Breathe Technologies BT-V2S ventilator, aims to assist individuals who have illnesses such as chronic obstructive pulmonary disease (COPD).
"This marks an important milestone for the future of COPD disease management and patient quality of life," said the manufacturer's president and CEO, Larry Mastrovich. "Patients with advanced COPD frequently suffer a loss of mobility, which may accelerate their respiratory disease progression and lead to decreased functional abilities."
He added that this type of healthcare management technology can help patients at home because it has the potential to improve their ability to perform daily tasks.
According to chairman John Miclot, the company is focusing on getting the device out onto the market so that patients who require ventilation assistance can benefit as soon as possible.
Such technology is becoming more commonly used in the field of healthcare, where it has been shown to not only improve disease management, but also to improve patient outcomes, reduce diagnostic errors, cut costs and save time.
source: medecision
About Breathe Technologies
Breathe Technologies, Inc., located in San Ramon, California, is a developer and manufacturer of innovative medical technologies for treating lung diseases and sleep-disordered breathing. The company was founded in January 2005, and their ventilator, featuring the company's proprietary, open-airway platform, is cleared for use in both the institutional and homecare settings.
CONTACT: Rebecca Mabry of Breathe Technologies, +1-925-359-1506, beckym@breathetechnologies.com
No comments:
Post a Comment